En la última década, 92 centros sanitarios andaluces, tanto públicos como privados, han colaborado con la industria farmacéutica innovadora en el desarrollo de 2.413 ensayos clínicos, en los q...
Read moreOryzon Genomics (ISIN Code: ES0167733015 , ORY ), a public clinical - stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced ...
Read moreSo far, this group of experts from the UB and IRBio have discovered bioactive molecules like hodgsonal, terpenoid acylglycerols, glassponsine, granuloside, illudalanes, triterpene glycosides, and some...
Read moreResearchers at the Centro Nacional de Biotecnología of the CSIC (CNB-CSIC) and the ALBA Synchrotron have now looked inside an infected cell in three dimensions and seen how the virus greatly distorts...
Read moreNostrum BioDiscovery has come about from the combined efforts of IRB Barcelona and the BSC-CNS—two research centres of excellence in Barcelona—with the participation of the University of Barcelona...
Read moreAvizorex Pharma –an ophthalmology biotech company with offices at Barcelona Science Park (PCB)– announcesthe submission of a Clinical Trial Application (CTA) to the Spanish Competent Authority, re...
Read moreTakeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels: TIG) (“TiGenix”) today announced that the companies have entered into an exclusive ex-U.S. li...
Read moreThe results, part of the EU Training Network BIOCASCADES, highlight the opportunities offered by developing multi-step processeses in a cascade fashion. This kind of all-enzymatic cascade, performed i...
Read moreFortalecer la colaboración público-privada en la investigación de excelencia. El Ministerio de Economía, Innovación y Competitividad, a través de la Secretaría de Estado de Investigación, Desa...
Read moreLa prestigiosa revista PLoS Pathogens acaba de publicar un artículo sobre los resultados del proyecto Malaria Box, una iniciativa de Medicine for Malaria Venture que ha facilitado el acceso abierto a...
Read moreTakeda and TiGenix Announce Publication in The Lancet of 24-Week Results of the Phase 3 ADMIRE-CD Trial Investigating Cx601 in the Treatment of Complex Perianal Fistulas in Patients with Crohn’s Dis...
Read more